[1] Al Sharabati, M.; Sabouni, R.; Husseini, G.A.,“ Biomedical Applications of Metal−Organic Frameworks for Disease Diagnosis and Drug Delivery: A Reviewˮ, Nanomaterials, 12(277) (2022). https://doi.org/10.3390/ nano12020277
[2] P. Tang, R. Wang, and Z. Chen, “In situ growth of Zr-based metal-organic framework UiO-66-NH2 for open-tubular capillary electrochromatographyˮ, Electrophoresis, 39(20) (2018), 2619–2625. https://doi.org/10.1002/elps.201800057
[3] I. Abánades Lázaro et al., “Surface-Functionalization of Zr-Fumarate MOF for Selective Cytotoxicity and Immune System Compatibility in Nanoscale Drug Delivery”, ACS Appl. Mater. Interfaces, 10(37) (2018), 31146–31157. https://doi.org/10.1021/acsami.8b11652
[4] He, Liangcan et al., “Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapyˮ, Nanomedicine (Lond), 14(10) (2019), 1343-1365. https://doi.org/10.2217/nnm-2018-0347
[5] Lu, Liangyu et al,“ Metal Organic Framework@Polysilsesequioxane Core/Shell-Structured Nanoplatform for Drug Deliveryˮ, Pharmaceutics, 12(98) (2020). https://doi.org/10.3390/pharmaceutics12020098
[6] El-Shafey, Aziza A M et al. , “Curcumin@metal organic frameworks nano-composite for treatment of chronic toxoplasmosisˮ, Materials Science Materials in Medicine, 31(11) (2020), 90. https://doi.org/10.1007/s10856-020-06429-y
[7] Abánades Lázaro, I., Wells, C. J. R., & Forgan, R. S, “Multivariate Modulation of the Zr MOF UiO-66 for Defect-Controlled Combination Anticancer Drug Delivery”, Angewandte Chemie (International ed. in English), 59(13) (2020), 5211-5217. https://doi.org/10.1002/anie.201915848
[8] Abánades Lázaro, Isabel et al, “Selective Surface PEGylation of UiO-66 Nanoparticles for Enhanced Stability, Cell Uptake, and pH-Responsive Drug Deliveryˮ, Chem, 2(4) (2017), 561–578. https://doi.org/10.1016/j.chempr.2017.02.005
[9] Isabel Abánades Lázaro, Ross S. Forgan, “Application of zirconium MOFs in drug delivery and biomedicineˮ, Coordination Chemistry Reviews, 380 (2019), 230–259. https://doi.org/10.1016/j.ccr.2018.09.009
[10] Gao, Yan et al., “Novel solid-phase extraction filter based on a zirconium meta-organic framework for determination of non-steroidal anti-inflammatory drugs residuesˮ, Chromatogr. A, 1652 (2021), 462349. https://doi.org/10.1016/j.chroma.2021.462349
[11] S. Yang et al., “A new post-synthetic polymerization strategy makes metal-organic frameworks more stableˮ, Chemical Science, 10(17) (2019), 4542–4549. http://dx.doi.org/10.1039/C9SC00135B
[12]
Ratna S. Katiyar,
Prateek K. Jha, “Molecular simulations in drug delivery : Opportunities and challengesˮ,
WIREs computational molecular science, 8(4) (2018), 1–18. https://doi.org/10.1002/wcms.1358
[13] Zhao, Huai-Xin et al., “Theranostic metal-organic framework core-shell composites for magnetic resonance imaging and drug deliveryˮ, Chemical science, 7(8) (2016), 5294–5301. https://doi.org/10.1039/C6SC01359G
[14] Cai, Mengru et al., “Metal Organic Frameworks as Drug Targeting Delivery Vehicles in the Treatment of Cancerˮ, Pharmaceutics, 12(3) (2020), 232. https://doi.org/10.3390/pharmaceutics12030232.
[15] C. Orellana-Tavra et al., “Amorphous metal-organic frameworks for drug delivery,” Chemical Communicatons, 51(73) (2015), 13878–13881. http://dx.doi.org/10.1039/C5CC05237H
[16] P. J. Jodłowski et al., “Cracking the Chloroquine Conundrum: The Application of Defective UiO-66 Metal-Organic Framework Materials to Prevent the Onset of Heart Defects: The Vivo and in Vitroˮ, ACS Applied Materials & Interfaces, 13(1) (2021), 312–323. https://doi.org/10.1021/acsami.0c21508
[17] B. Yang, M. Shen, J. Liu, and F. Ren, “Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cellsˮ, Pharmaceutical research, 34(11) (2017), 2440–2450. doi: 10.1007/s11095-017-2253-9
[18] A. Ray Chowdhuri, D. Bhattacharya, and S. K. Sahu, “Magnetic nanoscale metal organic frameworks for potential targeted anticancer drug delivery, imaging and as an MRI contrast agentˮ, Dalton Transactions, 45(7) (2016), 2963–2973. https://doi.org/10.1039/C5DT03736K
[19] M. X. Wu et al., “Multifunctional Supramolecular Materials Constructed from Polypyrrole@UiO-66 Nanohybrids and Pillararene Nanovalves for Targeted Chemophotothermal Therapyˮ, ACS Applied Materials & Interfaces, 10(40) (2018), 34655–34663. doi: 10.1021/acsami.8b13758.
[20] P. Abasian, S. Khalili, S. Ghanavati, and S. Rahebi, “Polymeric nanocarriers in targeted drug delivery systems : A reviewˮ,
polymers advanced technologies, 31(12) (2020), 2939-2954.
https://doi.org/10.1002/pat.5031
[21] S. Rojas et al., “Toward Understanding Drug Incorporation and Delivery from Biocompatible Metal-Organic Frameworks in View of Cutaneous Administration”, ACS Omega, 3(3) (2018), 2994–3003. https://doi.org/10.1021/acsomega.8b00185
[22] Orellana-Tavra, C., Mercado, S. A., & Fairen-Jimenez, D, “Endocytosis Mechanism of Nano Metal-Organic Frameworks for Drug Deliveryˮ, Advanced healthcare materials, 5(17) (2016), 2261–2270. https://doi.org/10.1002/adhm.201600296
[23]
sabel Abánades Lázaro et al., “Mechanistic investigation into the selective anticancer cytotoxicity and immune system nanoparticlesˮ,
ACS Applied Materials and Interfaces, 10(6) (2018), 5255–5268. https://doi.org/10.1021/acsami.7b17756
[24] Filippousi, Maria et al., “Biocompatible Zr-based nanoscale MOFs coated with modified poly (ε-caprolactone) as anticancer drug carriersˮ, International Journal of Pharmaceutics, 509(1-2) (2016), 208–218. https://doi.org/10.1016/j.ijpharm.2016.05.048
[25] Y. Liu et al., “ZrMOF nanoparticles as quenchers to conjugate DNA aptamers for target-induced bioimaging and photodynamic therapyˮ, Chemical Science, 9(38) (2018), 7505–7509. https://doi.org/10.1039/C8SC02210K
[26]
Hong Dong et al. , “Folic Acid Functionalized Zirconium-Based Metal–Organic Frameworks as Drug Carriers for Active Tumor-Targeted Drug Deliveryˮ,
Chemistry -A Euopean Jornal, 24(64) (2018), 17148–17154. https://doi.org/10.1002/chem.20180415
[27]
Jasmina Hafizovic Cavka et al., “A New Zirconium Inorganic Building Brick Forming Metal Organic Frameworks with Exceptional Stabilityˮ,
Journal of the American Chemical Society,
130(42) (2008), 13850–13851. https://doi.org/10.1021/ja8057953
[28] X. Zhu et al., “Inherent anchorages in UiO-66 nanoparticles for efficient capture of alendronate and its mediated releaseˮ, Chemical Communications, 50(63) (2014), 8779–8782. https://doi.org/10.1039/C4CC02570A
[29] Li, Zhen et al. “Functional groups influence and mechanism research of UiO-66-type metal-organic frameworks for ketoprofen delivery”, Colloids and surfaces. B, Biointerfaces, 178 (2019), 1-7. https://doi.org/10.1016/j.colsurfb.2019.02.027
[1] Al Sharabati, M.; Sabouni, R.; Husseini, G.A.,“ Biomedical Applications of Metal−Organic Frameworks for Disease Diagnosis and Drug Delivery: A Reviewˮ, Nanomaterials, 12(277) (2022). https://doi.org/10.3390/ nano12020277
[2] P. Tang, R. Wang, and Z. Chen, “In situ growth of Zr-based metal-organic framework UiO-66-NH2 for open-tubular capillary electrochromatographyˮ, Electrophoresis, 39(20) (2018), 2619–2625. https://doi.org/10.1002/elps.201800057
[3] I. Abánades Lázaro et al., “Surface-Functionalization of Zr-Fumarate MOF for Selective Cytotoxicity and Immune System Compatibility in Nanoscale Drug Delivery”, ACS Appl. Mater. Interfaces, 10(37) (2018), 31146–31157. https://doi.org/10.1021/acsami.8b11652
[4] He, Liangcan et al., “Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapyˮ, Nanomedicine (Lond), 14(10) (2019), 1343-1365. https://doi.org/10.2217/nnm-2018-0347
[5] Lu, Liangyu et al,“ Metal Organic Framework@Polysilsesequioxane Core/Shell-Structured Nanoplatform for Drug Deliveryˮ, Pharmaceutics, 12(98) (2020). https://doi.org/10.3390/pharmaceutics12020098
[6] El-Shafey, Aziza A M et al. , “Curcumin@metal organic frameworks nano-composite for treatment of chronic toxoplasmosisˮ, Materials Science Materials in Medicine, 31(11) (2020), 90. https://doi.org/10.1007/s10856-020-06429-y
[7] Abánades Lázaro, I., Wells, C. J. R., & Forgan, R. S, “Multivariate Modulation of the Zr MOF UiO-66 for Defect-Controlled Combination Anticancer Drug Delivery”, Angewandte Chemie (International ed. in English), 59(13) (2020), 5211-5217. https://doi.org/10.1002/anie.201915848
[8] Abánades Lázaro, Isabel et al, “Selective Surface PEGylation of UiO-66 Nanoparticles for Enhanced Stability, Cell Uptake, and pH-Responsive Drug Deliveryˮ, Chem, 2(4) (2017), 561–578. https://doi.org/10.1016/j.chempr.2017.02.005
[9] Isabel Abánades Lázaro, Ross S. Forgan, “Application of zirconium MOFs in drug delivery and biomedicineˮ, Coordination Chemistry Reviews, 380 (2019), 230–259. https://doi.org/10.1016/j.ccr.2018.09.009
[10] Gao, Yan et al., “Novel solid-phase extraction filter based on a zirconium meta-organic framework for determination of non-steroidal anti-inflammatory drugs residuesˮ, Chromatogr. A, 1652 (2021), 462349. https://doi.org/10.1016/j.chroma.2021.462349
[11] S. Yang et al., “A new post-synthetic polymerization strategy makes metal-organic frameworks more stableˮ, Chemical Science, 10(17) (2019), 4542–4549. http://dx.doi.org/10.1039/C9SC00135B
[12]
Ratna S. Katiyar,
Prateek K. Jha, “Molecular simulations in drug delivery : Opportunities and challengesˮ,
WIREs computational molecular science, 8(4) (2018), 1–18. https://doi.org/10.1002/wcms.1358
[13] Zhao, Huai-Xin et al., “Theranostic metal-organic framework core-shell composites for magnetic resonance imaging and drug deliveryˮ, Chemical science, 7(8) (2016), 5294–5301. https://doi.org/10.1039/C6SC01359G
[14] Cai, Mengru et al., “Metal Organic Frameworks as Drug Targeting Delivery Vehicles in the Treatment of Cancerˮ, Pharmaceutics, 12(3) (2020), 232. https://doi.org/10.3390/pharmaceutics12030232.
[15] C. Orellana-Tavra et al., “Amorphous metal-organic frameworks for drug delivery,” Chemical Communicatons, 51(73) (2015), 13878–13881. http://dx.doi.org/10.1039/C5CC05237H
[16] P. J. Jodłowski et al., “Cracking the Chloroquine Conundrum: The Application of Defective UiO-66 Metal-Organic Framework Materials to Prevent the Onset of Heart Defects: The Vivo and in Vitroˮ, ACS Applied Materials & Interfaces, 13(1) (2021), 312–323. https://doi.org/10.1021/acsami.0c21508
[17] B. Yang, M. Shen, J. Liu, and F. Ren, “Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cellsˮ, Pharmaceutical research, 34(11) (2017), 2440–2450. doi: 10.1007/s11095-017-2253-9
[18] A. Ray Chowdhuri, D. Bhattacharya, and S. K. Sahu, “Magnetic nanoscale metal organic frameworks for potential targeted anticancer drug delivery, imaging and as an MRI contrast agentˮ, Dalton Transactions, 45(7) (2016), 2963–2973. https://doi.org/10.1039/C5DT03736K
[19] M. X. Wu et al., “Multifunctional Supramolecular Materials Constructed from Polypyrrole@UiO-66 Nanohybrids and Pillararene Nanovalves for Targeted Chemophotothermal Therapyˮ, ACS Applied Materials & Interfaces, 10(40) (2018), 34655–34663. doi: 10.1021/acsami.8b13758.
[20] P. Abasian, S. Khalili, S. Ghanavati, and S. Rahebi, “Polymeric nanocarriers in targeted drug delivery systems : A reviewˮ,
polymers advanced technologies, 31(12) (2020), 2939-2954.
https://doi.org/10.1002/pat.5031
[21] S. Rojas et al., “Toward Understanding Drug Incorporation and Delivery from Biocompatible Metal-Organic Frameworks in View of Cutaneous Administration”, ACS Omega, 3(3) (2018), 2994–3003. https://doi.org/10.1021/acsomega.8b00185
[22] Orellana-Tavra, C., Mercado, S. A., & Fairen-Jimenez, D, “Endocytosis Mechanism of Nano Metal-Organic Frameworks for Drug Deliveryˮ, Advanced healthcare materials, 5(17) (2016), 2261–2270. https://doi.org/10.1002/adhm.201600296
[23]
sabel Abánades Lázaro et al., “Mechanistic investigation into the selective anticancer cytotoxicity and immune system nanoparticlesˮ,
ACS Applied Materials and Interfaces, 10(6) (2018), 5255–5268. https://doi.org/10.1021/acsami.7b17756
[24] Filippousi, Maria et al., “Biocompatible Zr-based nanoscale MOFs coated with modified poly (ε-caprolactone) as anticancer drug carriersˮ, International Journal of Pharmaceutics, 509(1-2) (2016), 208–218. https://doi.org/10.1016/j.ijpharm.2016.05.048
[25] Y. Liu et al., “ZrMOF nanoparticles as quenchers to conjugate DNA aptamers for target-induced bioimaging and photodynamic therapyˮ, Chemical Science, 9(38) (2018), 7505–7509. https://doi.org/10.1039/C8SC02210K
[26]
Hong Dong et al. , “Folic Acid Functionalized Zirconium-Based Metal–Organic Frameworks as Drug Carriers for Active Tumor-Targeted Drug Deliveryˮ,
Chemistry -A Euopean Jornal, 24(64) (2018), 17148–17154. https://doi.org/10.1002/chem.20180415
[27]
Jasmina Hafizovic Cavka et al., “A New Zirconium Inorganic Building Brick Forming Metal Organic Frameworks with Exceptional Stabilityˮ,
Journal of the American Chemical Society,
130(42) (2008), 13850–13851. https://doi.org/10.1021/ja8057953
[28] X. Zhu et al., “Inherent anchorages in UiO-66 nanoparticles for efficient capture of alendronate and its mediated releaseˮ, Chemical Communications, 50(63) (2014), 8779–8782. https://doi.org/10.1039/C4CC02570A
[29] Li, Zhen et al. “Functional groups influence and mechanism research of UiO-66-type metal-organic frameworks for ketoprofen delivery”, Colloids and surfaces. B, Biointerfaces, 178 (2019), 1-7. https://doi.org/10.1016/j.colsurfb.2019.02.027
[1] Al Sharabati, M.; Sabouni, R.; Husseini, G.A.,“ Biomedical Applications of Metal−Organic Frameworks for Disease Diagnosis and Drug Delivery: A Reviewˮ, Nanomaterials, 12(277) (2022). https://doi.org/10.3390/ nano12020277
[2] P. Tang, R. Wang, and Z. Chen, “In situ growth of Zr-based metal-organic framework UiO-66-NH2 for open-tubular capillary electrochromatographyˮ, Electrophoresis, 39(20) (2018), 2619–2625. https://doi.org/10.1002/elps.201800057
[3] I. Abánades Lázaro et al., “Surface-Functionalization of Zr-Fumarate MOF for Selective Cytotoxicity and Immune System Compatibility in Nanoscale Drug Delivery”, ACS Appl. Mater. Interfaces, 10(37) (2018), 31146–31157. https://doi.org/10.1021/acsami.8b11652
[4] He, Liangcan et al., “Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapyˮ, Nanomedicine (Lond), 14(10) (2019), 1343-1365. https://doi.org/10.2217/nnm-2018-0347
[5] Lu, Liangyu et al,“ Metal Organic Framework@Polysilsesequioxane Core/Shell-Structured Nanoplatform for Drug Deliveryˮ, Pharmaceutics, 12(98) (2020). https://doi.org/10.3390/pharmaceutics12020098
[6] El-Shafey, Aziza A M et al. , “Curcumin@metal organic frameworks nano-composite for treatment of chronic toxoplasmosisˮ, Materials Science Materials in Medicine, 31(11) (2020), 90. https://doi.org/10.1007/s10856-020-06429-y
[7] Abánades Lázaro, I., Wells, C. J. R., & Forgan, R. S, “Multivariate Modulation of the Zr MOF UiO-66 for Defect-Controlled Combination Anticancer Drug Delivery”, Angewandte Chemie (International ed. in English), 59(13) (2020), 5211-5217. https://doi.org/10.1002/anie.201915848
[8] Abánades Lázaro, Isabel et al, “Selective Surface PEGylation of UiO-66 Nanoparticles for Enhanced Stability, Cell Uptake, and pH-Responsive Drug Deliveryˮ, Chem, 2(4) (2017), 561–578. https://doi.org/10.1016/j.chempr.2017.02.005
[9] Isabel Abánades Lázaro, Ross S. Forgan, “Application of zirconium MOFs in drug delivery and biomedicineˮ, Coordination Chemistry Reviews, 380 (2019), 230–259. https://doi.org/10.1016/j.ccr.2018.09.009
[10] Gao, Yan et al., “Novel solid-phase extraction filter based on a zirconium meta-organic framework for determination of non-steroidal anti-inflammatory drugs residuesˮ, Chromatogr. A, 1652 (2021), 462349. https://doi.org/10.1016/j.chroma.2021.462349
[11] S. Yang et al., “A new post-synthetic polymerization strategy makes metal-organic frameworks more stableˮ, Chemical Science, 10(17) (2019), 4542–4549. http://dx.doi.org/10.1039/C9SC00135B
[12]
Ratna S. Katiyar,
Prateek K. Jha, “Molecular simulations in drug delivery : Opportunities and challengesˮ,
WIREs computational molecular science, 8(4) (2018), 1–18. https://doi.org/10.1002/wcms.1358
[13] Zhao, Huai-Xin et al., “Theranostic metal-organic framework core-shell composites for magnetic resonance imaging and drug deliveryˮ, Chemical science, 7(8) (2016), 5294–5301. https://doi.org/10.1039/C6SC01359G
[14] Cai, Mengru et al., “Metal Organic Frameworks as Drug Targeting Delivery Vehicles in the Treatment of Cancerˮ, Pharmaceutics, 12(3) (2020), 232. https://doi.org/10.3390/pharmaceutics12030232.
[15] C. Orellana-Tavra et al., “Amorphous metal-organic frameworks for drug delivery,” Chemical Communicatons, 51(73) (2015), 13878–13881. http://dx.doi.org/10.1039/C5CC05237H
[16] P. J. Jodłowski et al., “Cracking the Chloroquine Conundrum: The Application of Defective UiO-66 Metal-Organic Framework Materials to Prevent the Onset of Heart Defects: The Vivo and in Vitroˮ, ACS Applied Materials & Interfaces, 13(1) (2021), 312–323. https://doi.org/10.1021/acsami.0c21508
[17] B. Yang, M. Shen, J. Liu, and F. Ren, “Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cellsˮ, Pharmaceutical research, 34(11) (2017), 2440–2450. doi: 10.1007/s11095-017-2253-9
[18] A. Ray Chowdhuri, D. Bhattacharya, and S. K. Sahu, “Magnetic nanoscale metal organic frameworks for potential targeted anticancer drug delivery, imaging and as an MRI contrast agentˮ, Dalton Transactions, 45(7) (2016), 2963–2973. https://doi.org/10.1039/C5DT03736K
[19] M. X. Wu et al., “Multifunctional Supramolecular Materials Constructed from Polypyrrole@UiO-66 Nanohybrids and Pillararene Nanovalves for Targeted Chemophotothermal Therapyˮ, ACS Applied Materials & Interfaces, 10(40) (2018), 34655–34663. doi: 10.1021/acsami.8b13758.
[20] P. Abasian, S. Khalili, S. Ghanavati, and S. Rahebi, “Polymeric nanocarriers in targeted drug delivery systems : A reviewˮ,
polymers advanced technologies, 31(12) (2020), 2939-2954.
https://doi.org/10.1002/pat.5031
[21] S. Rojas et al., “Toward Understanding Drug Incorporation and Delivery from Biocompatible Metal-Organic Frameworks in View of Cutaneous Administration”, ACS Omega, 3(3) (2018), 2994–3003. https://doi.org/10.1021/acsomega.8b00185
[22] Orellana-Tavra, C., Mercado, S. A., & Fairen-Jimenez, D, “Endocytosis Mechanism of Nano Metal-Organic Frameworks for Drug Deliveryˮ, Advanced healthcare materials, 5(17) (2016), 2261–2270. https://doi.org/10.1002/adhm.201600296
[23]
sabel Abánades Lázaro et al., “Mechanistic investigation into the selective anticancer cytotoxicity and immune system nanoparticlesˮ,
ACS Applied Materials and Interfaces, 10(6) (2018), 5255–5268. https://doi.org/10.1021/acsami.7b17756
[24] Filippousi, Maria et al., “Biocompatible Zr-based nanoscale MOFs coated with modified poly (ε-caprolactone) as anticancer drug carriersˮ, International Journal of Pharmaceutics, 509(1-2) (2016), 208–218. https://doi.org/10.1016/j.ijpharm.2016.05.048
[25] Y. Liu et al., “ZrMOF nanoparticles as quenchers to conjugate DNA aptamers for target-induced bioimaging and photodynamic therapyˮ, Chemical Science, 9(38) (2018), 7505–7509. https://doi.org/10.1039/C8SC02210K
[26]
Hong Dong et al. , “Folic Acid Functionalized Zirconium-Based Metal–Organic Frameworks as Drug Carriers for Active Tumor-Targeted Drug Deliveryˮ,
Chemistry -A Euopean Jornal, 24(64) (2018), 17148–17154. https://doi.org/10.1002/chem.20180415
[27]
Jasmina Hafizovic Cavka et al., “A New Zirconium Inorganic Building Brick Forming Metal Organic Frameworks with Exceptional Stabilityˮ,
Journal of the American Chemical Society,
130(42) (2008), 13850–13851. https://doi.org/10.1021/ja8057953
[28] X. Zhu et al., “Inherent anchorages in UiO-66 nanoparticles for efficient capture of alendronate and its mediated releaseˮ, Chemical Communications, 50(63) (2014), 8779–8782. https://doi.org/10.1039/C4CC02570A
[29] Li, Zhen et al. “Functional groups influence and mechanism research of UiO-66-type metal-organic frameworks for ketoprofen delivery”, Colloids and surfaces. B, Biointerfaces, 178 (2019), 1-7. https://doi.org/10.1016/j.colsurfb.2019.02.027
[1] Al Sharabati, M.; Sabouni, R.; Husseini, G.A.,“ Biomedical Applications of Metal−Organic Frameworks for Disease Diagnosis and Drug Delivery: A Reviewˮ, Nanomaterials, 12(277) (2022). https://doi.org/10.3390/ nano12020277
[2] P. Tang, R. Wang, and Z. Chen, “In situ growth of Zr-based metal-organic framework UiO-66-NH2 for open-tubular capillary electrochromatographyˮ, Electrophoresis, 39(20) (2018), 2619–2625. https://doi.org/10.1002/elps.201800057
[3] I. Abánades Lázaro et al., “Surface-Functionalization of Zr-Fumarate MOF for Selective Cytotoxicity and Immune System Compatibility in Nanoscale Drug Delivery”, ACS Appl. Mater. Interfaces, 10(37) (2018), 31146–31157. https://doi.org/10.1021/acsami.8b11652
[4] He, Liangcan et al., “Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapyˮ, Nanomedicine (Lond), 14(10) (2019), 1343-1365. https://doi.org/10.2217/nnm-2018-0347
[5] Lu, Liangyu et al,“ Metal Organic Framework@Polysilsesequioxane Core/Shell-Structured Nanoplatform for Drug Deliveryˮ, Pharmaceutics, 12(98) (2020). https://doi.org/10.3390/pharmaceutics12020098
[6] El-Shafey, Aziza A M et al. , “Curcumin@metal organic frameworks nano-composite for treatment of chronic toxoplasmosisˮ, Materials Science Materials in Medicine, 31(11) (2020), 90. https://doi.org/10.1007/s10856-020-06429-y
[7] Abánades Lázaro, I., Wells, C. J. R., & Forgan, R. S, “Multivariate Modulation of the Zr MOF UiO-66 for Defect-Controlled Combination Anticancer Drug Delivery”, Angewandte Chemie (International ed. in English), 59(13) (2020), 5211-5217. https://doi.org/10.1002/anie.201915848
[8] Abánades Lázaro, Isabel et al, “Selective Surface PEGylation of UiO-66 Nanoparticles for Enhanced Stability, Cell Uptake, and pH-Responsive Drug Deliveryˮ, Chem, 2(4) (2017), 561–578. https://doi.org/10.1016/j.chempr.2017.02.005
[9] Isabel Abánades Lázaro, Ross S. Forgan, “Application of zirconium MOFs in drug delivery and biomedicineˮ, Coordination Chemistry Reviews, 380 (2019), 230–259. https://doi.org/10.1016/j.ccr.2018.09.009
[10] Gao, Yan et al., “Novel solid-phase extraction filter based on a zirconium meta-organic framework for determination of non-steroidal anti-inflammatory drugs residuesˮ, Chromatogr. A, 1652 (2021), 462349. https://doi.org/10.1016/j.chroma.2021.462349
[11] S. Yang et al., “A new post-synthetic polymerization strategy makes metal-organic frameworks more stableˮ, Chemical Science, 10(17) (2019), 4542–4549. http://dx.doi.org/10.1039/C9SC00135B
[12]
Ratna S. Katiyar,
Prateek K. Jha, “Molecular simulations in drug delivery : Opportunities and challengesˮ,
WIREs computational molecular science, 8(4) (2018), 1–18. https://doi.org/10.1002/wcms.1358
[13] Zhao, Huai-Xin et al., “Theranostic metal-organic framework core-shell composites for magnetic resonance imaging and drug deliveryˮ, Chemical science, 7(8) (2016), 5294–5301. https://doi.org/10.1039/C6SC01359G
[14] Cai, Mengru et al., “Metal Organic Frameworks as Drug Targeting Delivery Vehicles in the Treatment of Cancerˮ, Pharmaceutics, 12(3) (2020), 232. https://doi.org/10.3390/pharmaceutics12030232.
[15] C. Orellana-Tavra et al., “Amorphous metal-organic frameworks for drug delivery,” Chemical Communicatons, 51(73) (2015), 13878–13881. http://dx.doi.org/10.1039/C5CC05237H
[16] P. J. Jodłowski et al., “Cracking the Chloroquine Conundrum: The Application of Defective UiO-66 Metal-Organic Framework Materials to Prevent the Onset of Heart Defects: The Vivo and in Vitroˮ, ACS Applied Materials & Interfaces, 13(1) (2021), 312–323. https://doi.org/10.1021/acsami.0c21508
[17] B. Yang, M. Shen, J. Liu, and F. Ren, “Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cellsˮ, Pharmaceutical research, 34(11) (2017), 2440–2450. doi: 10.1007/s11095-017-2253-9
[18] A. Ray Chowdhuri, D. Bhattacharya, and S. K. Sahu, “Magnetic nanoscale metal organic frameworks for potential targeted anticancer drug delivery, imaging and as an MRI contrast agentˮ, Dalton Transactions, 45(7) (2016), 2963–2973. https://doi.org/10.1039/C5DT03736K
[19] M. X. Wu et al., “Multifunctional Supramolecular Materials Constructed from Polypyrrole@UiO-66 Nanohybrids and Pillararene Nanovalves for Targeted Chemophotothermal Therapyˮ, ACS Applied Materials & Interfaces, 10(40) (2018), 34655–34663. doi: 10.1021/acsami.8b13758.
[20] P. Abasian, S. Khalili, S. Ghanavati, and S. Rahebi, “Polymeric nanocarriers in targeted drug delivery systems : A reviewˮ,
polymers advanced technologies, 31(12) (2020), 2939-2954.
https://doi.org/10.1002/pat.5031
[21] S. Rojas et al., “Toward Understanding Drug Incorporation and Delivery from Biocompatible Metal-Organic Frameworks in View of Cutaneous Administration”, ACS Omega, 3(3) (2018), 2994–3003. https://doi.org/10.1021/acsomega.8b00185
[22] Orellana-Tavra, C., Mercado, S. A., & Fairen-Jimenez, D, “Endocytosis Mechanism of Nano Metal-Organic Frameworks for Drug Deliveryˮ, Advanced healthcare materials, 5(17) (2016), 2261–2270. https://doi.org/10.1002/adhm.201600296
[23]
sabel Abánades Lázaro et al., “Mechanistic investigation into the selective anticancer cytotoxicity and immune system nanoparticlesˮ,
ACS Applied Materials and Interfaces, 10(6) (2018), 5255–5268. https://doi.org/10.1021/acsami.7b17756
[24] Filippousi, Maria et al., “Biocompatible Zr-based nanoscale MOFs coated with modified poly (ε-caprolactone) as anticancer drug carriersˮ, International Journal of Pharmaceutics, 509(1-2) (2016), 208–218. https://doi.org/10.1016/j.ijpharm.2016.05.048
[25] Y. Liu et al., “ZrMOF nanoparticles as quenchers to conjugate DNA aptamers for target-induced bioimaging and photodynamic therapyˮ, Chemical Science, 9(38) (2018), 7505–7509. https://doi.org/10.1039/C8SC02210K
[26]
Hong Dong et al. , “Folic Acid Functionalized Zirconium-Based Metal–Organic Frameworks as Drug Carriers for Active Tumor-Targeted Drug Deliveryˮ,
Chemistry -A Euopean Jornal, 24(64) (2018), 17148–17154. https://doi.org/10.1002/chem.20180415
[27]
Jasmina Hafizovic Cavka et al., “A New Zirconium Inorganic Building Brick Forming Metal Organic Frameworks with Exceptional Stabilityˮ,
Journal of the American Chemical Society,
130(42) (2008), 13850–13851. https://doi.org/10.1021/ja8057953
[28] X. Zhu et al., “Inherent anchorages in UiO-66 nanoparticles for efficient capture of alendronate and its mediated releaseˮ, Chemical Communications, 50(63) (2014), 8779–8782. https://doi.org/10.1039/C4CC02570A
[29] Li, Zhen et al. “Functional groups influence and mechanism research of UiO-66-type metal-organic frameworks for ketoprofen delivery”, Colloids and surfaces. B, Biointerfaces, 178 (2019), 1-7. https://doi.org/10.1016/j.colsurfb.2019.02.027
[1] Al Sharabati, M.; Sabouni, R.; Husseini, G.A.,“ Biomedical Applications of Metal−Organic Frameworks for Disease Diagnosis and Drug Delivery: A Reviewˮ, Nanomaterials, 12(277) (2022). https://doi.org/10.3390/ nano12020277
[2] P. Tang, R. Wang, and Z. Chen, “In situ growth of Zr-based metal-organic framework UiO-66-NH2 for open-tubular capillary electrochromatographyˮ, Electrophoresis, 39(20) (2018), 2619–2625. https://doi.org/10.1002/elps.201800057
[3] I. Abánades Lázaro et al., “Surface-Functionalization of Zr-Fumarate MOF for Selective Cytotoxicity and Immune System Compatibility in Nanoscale Drug Delivery”, ACS Appl. Mater. Interfaces, 10(37) (2018), 31146–31157. https://doi.org/10.1021/acsami.8b11652
[4] He, Liangcan et al., “Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapyˮ, Nanomedicine (Lond), 14(10) (2019), 1343-1365. https://doi.org/10.2217/nnm-2018-0347
[5] Lu, Liangyu et al,“ Metal Organic Framework@Polysilsesequioxane Core/Shell-Structured Nanoplatform for Drug Deliveryˮ, Pharmaceutics, 12(98) (2020). https://doi.org/10.3390/pharmaceutics12020098
[6] El-Shafey, Aziza A M et al. , “Curcumin@metal organic frameworks nano-composite for treatment of chronic toxoplasmosisˮ, Materials Science Materials in Medicine, 31(11) (2020), 90. https://doi.org/10.1007/s10856-020-06429-y
[7] Abánades Lázaro, I., Wells, C. J. R., & Forgan, R. S, “Multivariate Modulation of the Zr MOF UiO-66 for Defect-Controlled Combination Anticancer Drug Delivery”, Angewandte Chemie (International ed. in English), 59(13) (2020), 5211-5217. https://doi.org/10.1002/anie.201915848
[8] Abánades Lázaro, Isabel et al, “Selective Surface PEGylation of UiO-66 Nanoparticles for Enhanced Stability, Cell Uptake, and pH-Responsive Drug Deliveryˮ, Chem, 2(4) (2017), 561–578. https://doi.org/10.1016/j.chempr.2017.02.005
[9] Isabel Abánades Lázaro, Ross S. Forgan, “Application of zirconium MOFs in drug delivery and biomedicineˮ, Coordination Chemistry Reviews, 380 (2019), 230–259. https://doi.org/10.1016/j.ccr.2018.09.009
[10] Gao, Yan et al., “Novel solid-phase extraction filter based on a zirconium meta-organic framework for determination of non-steroidal anti-inflammatory drugs residuesˮ, Chromatogr. A, 1652 (2021), 462349. https://doi.org/10.1016/j.chroma.2021.462349
[11] S. Yang et al., “A new post-synthetic polymerization strategy makes metal-organic frameworks more stableˮ, Chemical Science, 10(17) (2019), 4542–4549. http://dx.doi.org/10.1039/C9SC00135B
[12]
Ratna S. Katiyar,
Prateek K. Jha, “Molecular simulations in drug delivery : Opportunities and challengesˮ,
WIREs computational molecular science, 8(4) (2018), 1–18. https://doi.org/10.1002/wcms.1358
[13] Zhao, Huai-Xin et al., “Theranostic metal-organic framework core-shell composites for magnetic resonance imaging and drug deliveryˮ, Chemical science, 7(8) (2016), 5294–5301. https://doi.org/10.1039/C6SC01359G
[14] Cai, Mengru et al., “Metal Organic Frameworks as Drug Targeting Delivery Vehicles in the Treatment of Cancerˮ, Pharmaceutics, 12(3) (2020), 232. https://doi.org/10.3390/pharmaceutics12030232.
[15] C. Orellana-Tavra et al., “Amorphous metal-organic frameworks for drug delivery,” Chemical Communicatons, 51(73) (2015), 13878–13881. http://dx.doi.org/10.1039/C5CC05237H
[16] P. J. Jodłowski et al., “Cracking the Chloroquine Conundrum: The Application of Defective UiO-66 Metal-Organic Framework Materials to Prevent the Onset of Heart Defects: The Vivo and in Vitroˮ, ACS Applied Materials & Interfaces, 13(1) (2021), 312–323. https://doi.org/10.1021/acsami.0c21508
[17] B. Yang, M. Shen, J. Liu, and F. Ren, “Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cellsˮ, Pharmaceutical research, 34(11) (2017), 2440–2450. doi: 10.1007/s11095-017-2253-9
[18] A. Ray Chowdhuri, D. Bhattacharya, and S. K. Sahu, “Magnetic nanoscale metal organic frameworks for potential targeted anticancer drug delivery, imaging and as an MRI contrast agentˮ, Dalton Transactions, 45(7) (2016), 2963–2973. https://doi.org/10.1039/C5DT03736K
[19] M. X. Wu et al., “Multifunctional Supramolecular Materials Constructed from Polypyrrole@UiO-66 Nanohybrids and Pillararene Nanovalves for Targeted Chemophotothermal Therapyˮ, ACS Applied Materials & Interfaces, 10(40) (2018), 34655–34663. doi: 10.1021/acsami.8b13758.
[20] P. Abasian, S. Khalili, S. Ghanavati, and S. Rahebi, “Polymeric nanocarriers in targeted drug delivery systems : A reviewˮ,
polymers advanced technologies, 31(12) (2020), 2939-2954.
https://doi.org/10.1002/pat.5031
[21] S. Rojas et al., “Toward Understanding Drug Incorporation and Delivery from Biocompatible Metal-Organic Frameworks in View of Cutaneous Administration”, ACS Omega, 3(3) (2018), 2994–3003. https://doi.org/10.1021/acsomega.8b00185
[22] Orellana-Tavra, C., Mercado, S. A., & Fairen-Jimenez, D, “Endocytosis Mechanism of Nano Metal-Organic Frameworks for Drug Deliveryˮ, Advanced healthcare materials, 5(17) (2016), 2261–2270. https://doi.org/10.1002/adhm.201600296
[23]
sabel Abánades Lázaro et al., “Mechanistic investigation into the selective anticancer cytotoxicity and immune system nanoparticlesˮ,
ACS Applied Materials and Interfaces, 10(6) (2018), 5255–5268. https://doi.org/10.1021/acsami.7b17756
[24] Filippousi, Maria et al., “Biocompatible Zr-based nanoscale MOFs coated with modified poly (ε-caprolactone) as anticancer drug carriersˮ, International Journal of Pharmaceutics, 509(1-2) (2016), 208–218. https://doi.org/10.1016/j.ijpharm.2016.05.048
[25] Y. Liu et al., “ZrMOF nanoparticles as quenchers to conjugate DNA aptamers for target-induced bioimaging and photodynamic therapyˮ, Chemical Science, 9(38) (2018), 7505–7509. https://doi.org/10.1039/C8SC02210K
[26]
Hong Dong et al. , “Folic Acid Functionalized Zirconium-Based Metal–Organic Frameworks as Drug Carriers for Active Tumor-Targeted Drug Deliveryˮ,
Chemistry -A Euopean Jornal, 24(64) (2018), 17148–17154. https://doi.org/10.1002/chem.20180415
[27]
Jasmina Hafizovic Cavka et al., “A New Zirconium Inorganic Building Brick Forming Metal Organic Frameworks with Exceptional Stabilityˮ,
Journal of the American Chemical Society,
130(42) (2008), 13850–13851. https://doi.org/10.1021/ja8057953
[28] X. Zhu et al., “Inherent anchorages in UiO-66 nanoparticles for efficient capture of alendronate and its mediated releaseˮ, Chemical Communications, 50(63) (2014), 8779–8782. https://doi.org/10.1039/C4CC02570A
[29] Li, Zhen et al. “Functional groups influence and mechanism research of UiO-66-type metal-organic frameworks for ketoprofen delivery”, Colloids and surfaces. B, Biointerfaces, 178 (2019), 1-7. https://doi.org/10.1016/j.colsurfb.2019.02.027
[1] Al Sharabati, M.; Sabouni, R.; Husseini, G.A.,“ Biomedical Applications of Metal−Organic Frameworks for Disease Diagnosis and Drug Delivery: A Reviewˮ, Nanomaterials, 12(277) (2022). https://doi.org/10.3390/ nano12020277
[2] P. Tang, R. Wang, and Z. Chen, “In situ growth of Zr-based metal-organic framework UiO-66-NH2 for open-tubular capillary electrochromatographyˮ, Electrophoresis, 39(20) (2018), 2619–2625. https://doi.org/10.1002/elps.201800057
[3] I. Abánades Lázaro et al., “Surface-Functionalization of Zr-Fumarate MOF for Selective Cytotoxicity and Immune System Compatibility in Nanoscale Drug Delivery”, ACS Appl. Mater. Interfaces, 10(37) (2018), 31146–31157. https://doi.org/10.1021/acsami.8b11652
[4] He, Liangcan et al., “Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapyˮ, Nanomedicine (Lond), 14(10) (2019), 1343-1365. https://doi.org/10.2217/nnm-2018-0347
[5] Lu, Liangyu et al,“ Metal Organic Framework@Polysilsesequioxane Core/Shell-Structured Nanoplatform for Drug Deliveryˮ, Pharmaceutics, 12(98) (2020). https://doi.org/10.3390/pharmaceutics12020098
[6] El-Shafey, Aziza A M et al. , “Curcumin@metal organic frameworks nano-composite for treatment of chronic toxoplasmosisˮ, Materials Science Materials in Medicine, 31(11) (2020), 90. https://doi.org/10.1007/s10856-020-06429-y
[7] Abánades Lázaro, I., Wells, C. J. R., & Forgan, R. S, “Multivariate Modulation of the Zr MOF UiO-66 for Defect-Controlled Combination Anticancer Drug Delivery”, Angewandte Chemie (International ed. in English), 59(13) (2020), 5211-5217. https://doi.org/10.1002/anie.201915848
[8] Abánades Lázaro, Isabel et al, “Selective Surface PEGylation of UiO-66 Nanoparticles for Enhanced Stability, Cell Uptake, and pH-Responsive Drug Deliveryˮ, Chem, 2(4) (2017), 561–578. https://doi.org/10.1016/j.chempr.2017.02.005
[9] Isabel Abánades Lázaro, Ross S. Forgan, “Application of zirconium MOFs in drug delivery and biomedicineˮ, Coordination Chemistry Reviews, 380 (2019), 230–259. https://doi.org/10.1016/j.ccr.2018.09.009
[10] Gao, Yan et al., “Novel solid-phase extraction filter based on a zirconium meta-organic framework for determination of non-steroidal anti-inflammatory drugs residuesˮ, Chromatogr. A, 1652 (2021), 462349. https://doi.org/10.1016/j.chroma.2021.462349
[11] S. Yang et al., “A new post-synthetic polymerization strategy makes metal-organic frameworks more stableˮ, Chemical Science, 10(17) (2019), 4542–4549. http://dx.doi.org/10.1039/C9SC00135B
[12]
Ratna S. Katiyar,
Prateek K. Jha, “Molecular simulations in drug delivery : Opportunities and challengesˮ,
WIREs computational molecular science, 8(4) (2018), 1–18. https://doi.org/10.1002/wcms.1358
[13] Zhao, Huai-Xin et al., “Theranostic metal-organic framework core-shell composites for magnetic resonance imaging and drug deliveryˮ, Chemical science, 7(8) (2016), 5294–5301. https://doi.org/10.1039/C6SC01359G
[14] Cai, Mengru et al., “Metal Organic Frameworks as Drug Targeting Delivery Vehicles in the Treatment of Cancerˮ, Pharmaceutics, 12(3) (2020), 232. https://doi.org/10.3390/pharmaceutics12030232.
[15] C. Orellana-Tavra et al., “Amorphous metal-organic frameworks for drug delivery,” Chemical Communicatons, 51(73) (2015), 13878–13881. http://dx.doi.org/10.1039/C5CC05237H
[16] P. J. Jodłowski et al., “Cracking the Chloroquine Conundrum: The Application of Defective UiO-66 Metal-Organic Framework Materials to Prevent the Onset of Heart Defects: The Vivo and in Vitroˮ, ACS Applied Materials & Interfaces, 13(1) (2021), 312–323. https://doi.org/10.1021/acsami.0c21508
[17] B. Yang, M. Shen, J. Liu, and F. Ren, “Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cellsˮ, Pharmaceutical research, 34(11) (2017), 2440–2450. doi: 10.1007/s11095-017-2253-9
[18] A. Ray Chowdhuri, D. Bhattacharya, and S. K. Sahu, “Magnetic nanoscale metal organic frameworks for potential targeted anticancer drug delivery, imaging and as an MRI contrast agentˮ, Dalton Transactions, 45(7) (2016), 2963–2973. https://doi.org/10.1039/C5DT03736K
[19] M. X. Wu et al., “Multifunctional Supramolecular Materials Constructed from Polypyrrole@UiO-66 Nanohybrids and Pillararene Nanovalves for Targeted Chemophotothermal Therapyˮ, ACS Applied Materials & Interfaces, 10(40) (2018), 34655–34663. doi: 10.1021/acsami.8b13758.
[20] P. Abasian, S. Khalili, S. Ghanavati, and S. Rahebi, “Polymeric nanocarriers in targeted drug delivery systems : A reviewˮ,
polymers advanced technologies, 31(12) (2020), 2939-2954.
https://doi.org/10.1002/pat.5031
[21] S. Rojas et al., “Toward Understanding Drug Incorporation and Delivery from Biocompatible Metal-Organic Frameworks in View of Cutaneous Administration”, ACS Omega, 3(3) (2018), 2994–3003. https://doi.org/10.1021/acsomega.8b00185
[22] Orellana-Tavra, C., Mercado, S. A., & Fairen-Jimenez, D, “Endocytosis Mechanism of Nano Metal-Organic Frameworks for Drug Deliveryˮ, Advanced healthcare materials, 5(17) (2016), 2261–2270. https://doi.org/10.1002/adhm.201600296
[23]
sabel Abánades Lázaro et al., “Mechanistic investigation into the selective anticancer cytotoxicity and immune system nanoparticlesˮ,
ACS Applied Materials and Interfaces, 10(6) (2018), 5255–5268. https://doi.org/10.1021/acsami.7b17756
[24] Filippousi, Maria et al., “Biocompatible Zr-based nanoscale MOFs coated with modified poly (ε-caprolactone) as anticancer drug carriersˮ, International Journal of Pharmaceutics, 509(1-2) (2016), 208–218. https://doi.org/10.1016/j.ijpharm.2016.05.048
[25] Y. Liu et al., “ZrMOF nanoparticles as quenchers to conjugate DNA aptamers for target-induced bioimaging and photodynamic therapyˮ, Chemical Science, 9(38) (2018), 7505–7509. https://doi.org/10.1039/C8SC02210K
[26]
Hong Dong et al. , “Folic Acid Functionalized Zirconium-Based Metal–Organic Frameworks as Drug Carriers for Active Tumor-Targeted Drug Deliveryˮ,
Chemistry -A Euopean Jornal, 24(64) (2018), 17148–17154. https://doi.org/10.1002/chem.20180415
[27]
Jasmina Hafizovic Cavka et al., “A New Zirconium Inorganic Building Brick Forming Metal Organic Frameworks with Exceptional Stabilityˮ,
Journal of the American Chemical Society,
130(42) (2008), 13850–13851. https://doi.org/10.1021/ja8057953
[28] X. Zhu et al., “Inherent anchorages in UiO-66 nanoparticles for efficient capture of alendronate and its mediated releaseˮ, Chemical Communications, 50(63) (2014), 8779–8782. https://doi.org/10.1039/C4CC02570A
[29] Li, Zhen et al. “Functional groups influence and mechanism research of UiO-66-type metal-organic frameworks for ketoprofen delivery”, Colloids and surfaces. B, Biointerfaces, 178 (2019), 1-7. https://doi.org/10.1016/j.colsurfb.2019.02.027
[1] Al Sharabati, M.; Sabouni, R.; Husseini, G.A.,“ Biomedical Applications of Metal−Organic Frameworks for Disease Diagnosis and Drug Delivery: A Reviewˮ, Nanomaterials, 12(277) (2022). https://doi.org/10.3390/ nano12020277
[2] P. Tang, R. Wang, and Z. Chen, “In situ growth of Zr-based metal-organic framework UiO-66-NH2 for open-tubular capillary electrochromatographyˮ, Electrophoresis, 39(20) (2018), 2619–2625. https://doi.org/10.1002/elps.201800057
[3] I. Abánades Lázaro et al., “Surface-Functionalization of Zr-Fumarate MOF for Selective Cytotoxicity and Immune System Compatibility in Nanoscale Drug Delivery”, ACS Appl. Mater. Interfaces, 10(37) (2018), 31146–31157. https://doi.org/10.1021/acsami.8b11652
[4] He, Liangcan et al., “Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapyˮ, Nanomedicine (Lond), 14(10) (2019), 1343-1365. https://doi.org/10.2217/nnm-2018-0347
[5] Lu, Liangyu et al,“ Metal Organic Framework@Polysilsesequioxane Core/Shell-Structured Nanoplatform for Drug Deliveryˮ, Pharmaceutics, 12(98) (2020). https://doi.org/10.3390/pharmaceutics12020098
[6] El-Shafey, Aziza A M et al. , “Curcumin@metal organic frameworks nano-composite for treatment of chronic toxoplasmosisˮ, Materials Science Materials in Medicine, 31(11) (2020), 90. https://doi.org/10.1007/s10856-020-06429-y
[7] Abánades Lázaro, I., Wells, C. J. R., & Forgan, R. S, “Multivariate Modulation of the Zr MOF UiO-66 for Defect-Controlled Combination Anticancer Drug Delivery”, Angewandte Chemie (International ed. in English), 59(13) (2020), 5211-5217. https://doi.org/10.1002/anie.201915848
[8] Abánades Lázaro, Isabel et al, “Selective Surface PEGylation of UiO-66 Nanoparticles for Enhanced Stability, Cell Uptake, and pH-Responsive Drug Deliveryˮ, Chem, 2(4) (2017), 561–578. https://doi.org/10.1016/j.chempr.2017.02.005
[9] Isabel Abánades Lázaro, Ross S. Forgan, “Application of zirconium MOFs in drug delivery and biomedicineˮ, Coordination Chemistry Reviews, 380 (2019), 230–259. https://doi.org/10.1016/j.ccr.2018.09.009
[10] Gao, Yan et al., “Novel solid-phase extraction filter based on a zirconium meta-organic framework for determination of non-steroidal anti-inflammatory drugs residuesˮ, Chromatogr. A, 1652 (2021), 462349. https://doi.org/10.1016/j.chroma.2021.462349
[11] S. Yang et al., “A new post-synthetic polymerization strategy makes metal-organic frameworks more stableˮ, Chemical Science, 10(17) (2019), 4542–4549. http://dx.doi.org/10.1039/C9SC00135B
[12]
Ratna S. Katiyar,
Prateek K. Jha, “Molecular simulations in drug delivery : Opportunities and challengesˮ,
WIREs computational molecular science, 8(4) (2018), 1–18. https://doi.org/10.1002/wcms.1358
[13] Zhao, Huai-Xin et al., “Theranostic metal-organic framework core-shell composites for magnetic resonance imaging and drug deliveryˮ, Chemical science, 7(8) (2016), 5294–5301. https://doi.org/10.1039/C6SC01359G
[14] Cai, Mengru et al., “Metal Organic Frameworks as Drug Targeting Delivery Vehicles in the Treatment of Cancerˮ, Pharmaceutics, 12(3) (2020), 232. https://doi.org/10.3390/pharmaceutics12030232.
[15] C. Orellana-Tavra et al., “Amorphous metal-organic frameworks for drug delivery,” Chemical Communicatons, 51(73) (2015), 13878–13881. http://dx.doi.org/10.1039/C5CC05237H
[16] P. J. Jodłowski et al., “Cracking the Chloroquine Conundrum: The Application of Defective UiO-66 Metal-Organic Framework Materials to Prevent the Onset of Heart Defects: The Vivo and in Vitroˮ, ACS Applied Materials & Interfaces, 13(1) (2021), 312–323. https://doi.org/10.1021/acsami.0c21508
[17] B. Yang, M. Shen, J. Liu, and F. Ren, “Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cellsˮ, Pharmaceutical research, 34(11) (2017), 2440–2450. doi: 10.1007/s11095-017-2253-9
[18] A. Ray Chowdhuri, D. Bhattacharya, and S. K. Sahu, “Magnetic nanoscale metal organic frameworks for potential targeted anticancer drug delivery, imaging and as an MRI contrast agentˮ, Dalton Transactions, 45(7) (2016), 2963–2973. https://doi.org/10.1039/C5DT03736K
[19] M. X. Wu et al., “Multifunctional Supramolecular Materials Constructed from Polypyrrole@UiO-66 Nanohybrids and Pillararene Nanovalves for Targeted Chemophotothermal Therapyˮ, ACS Applied Materials & Interfaces, 10(40) (2018), 34655–34663. doi: 10.1021/acsami.8b13758.
[20] P. Abasian, S. Khalili, S. Ghanavati, and S. Rahebi, “Polymeric nanocarriers in targeted drug delivery systems : A reviewˮ,
polymers advanced technologies, 31(12) (2020), 2939-2954.
https://doi.org/10.1002/pat.5031
[21] S. Rojas et al., “Toward Understanding Drug Incorporation and Delivery from Biocompatible Metal-Organic Frameworks in View of Cutaneous Administration”, ACS Omega, 3(3) (2018), 2994–3003. https://doi.org/10.1021/acsomega.8b00185
[22] Orellana-Tavra, C., Mercado, S. A., & Fairen-Jimenez, D, “Endocytosis Mechanism of Nano Metal-Organic Frameworks for Drug Deliveryˮ, Advanced healthcare materials, 5(17) (2016), 2261–2270. https://doi.org/10.1002/adhm.201600296
[23]
sabel Abánades Lázaro et al., “Mechanistic investigation into the selective anticancer cytotoxicity and immune system nanoparticlesˮ,
ACS Applied Materials and Interfaces, 10(6) (2018), 5255–5268. https://doi.org/10.1021/acsami.7b17756
[24] Filippousi, Maria et al., “Biocompatible Zr-based nanoscale MOFs coated with modified poly (ε-caprolactone) as anticancer drug carriersˮ, International Journal of Pharmaceutics, 509(1-2) (2016), 208–218. https://doi.org/10.1016/j.ijpharm.2016.05.048
[25] Y. Liu et al., “ZrMOF nanoparticles as quenchers to conjugate DNA aptamers for target-induced bioimaging and photodynamic therapyˮ, Chemical Science, 9(38) (2018), 7505–7509. https://doi.org/10.1039/C8SC02210K
[26]
Hong Dong et al. , “Folic Acid Functionalized Zirconium-Based Metal–Organic Frameworks as Drug Carriers for Active Tumor-Targeted Drug Deliveryˮ,
Chemistry -A Euopean Jornal, 24(64) (2018), 17148–17154. https://doi.org/10.1002/chem.20180415
[27]
Jasmina Hafizovic Cavka et al., “A New Zirconium Inorganic Building Brick Forming Metal Organic Frameworks with Exceptional Stabilityˮ,
Journal of the American Chemical Society,
130(42) (2008), 13850–13851. https://doi.org/10.1021/ja8057953
[28] X. Zhu et al., “Inherent anchorages in UiO-66 nanoparticles for efficient capture of alendronate and its mediated releaseˮ, Chemical Communications, 50(63) (2014), 8779–8782. https://doi.org/10.1039/C4CC02570A
[29] Li, Zhen et al. “Functional groups influence and mechanism research of UiO-66-type metal-organic frameworks for ketoprofen delivery”, Colloids and surfaces. B, Biointerfaces, 178 (2019), 1-7. https://doi.org/10.1016/j.colsurfb.2019.02.027